Holen Sie sich die Stockscreener-App
0.3277
1.71%
-0.0057
Handel nachbörslich:
.52
0.1923
+58.68%
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
17.36%
1.474
|
1.256 | - | 1.211 | 1.163 |
| Cost Of Revenue |
11.08%
1.445
|
1.625 | - | - | - |
| Research and Development |
1.16%
1.192
|
1.206 | 1.723 | - | - |
| Costs And Expenses |
6.77%
14.28
|
13.37 | - | 11.61 | 5.602 |
| Operating Income/Loss |
5.67%
-12.80
|
-12.11 | -14.01 | -11.76 | -11.38 |
| Nonoperating Income/Loss |
162.06%
1.114
|
-1.795 | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
15.98%
-11.69
|
-13.91 | -16.27 | -10.40 | -4.439 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
15.98%
-11.69
|
-13.91 | -16.27 | -10.40 | -4.439 |
| Preferred Stock Dividends And Other Adjustments |
68.84%
3.028
|
9.719 | - | - | 3.449 |
| Basic Average Shares |
30.71%
183.12
|
140.10 | - | 108.18 | 98.99 |
| Basic Earnings Per Share |
52.94%
-0.08
|
-0.17 | - | -0.10 | -0.08 |
0.19%
3.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):